Ernesto Trallero‐Araguás

Influence of Antisynthetase Antibodies Specificities on Antisynthetase Syndrome Clinical Spectrum Time Course

Lorenzo Cavagna, Ernesto Trallero‐Araguás, Federica Meloni et al. · Journal of Clinical Medicine · 2019 · 214 citations · Full text

Life Sciences, Immunology, Internal Medicine +15

Anti-MDA5 Antibodies in a Large Mediterranean Population of Adults with Dermatomyositis

Moisés Labrador‐Horrillo, María Ángeles Martínez, Albert Selva-O’Callaghan et al. · Journal of Immunology Research · 2014 · 188 citations · Full text

Life Sciences, Dermatology, Immunology +17

Recommendations for the treatment of anti-melanoma differentiation-associated gene 5-positive dermatomyositis-associated rapidly progressive interstitial lung disease

Fredeswinda Romero-Bueno, P. Díaz del Campo, Ernesto Trallero‐Araguás et al. · Seminars in Arthritis and Rheumatism · 2020 · 182 citations · Full text

Medicine, Dermatology, Oncology +14

Incidence of COVID-19 in a cohort of adult and paediatric patients with rheumatic diseases treated with targeted biologic and synthetic disease-modifying anti-rheumatic drugs

Xabier Michelena, Helena Borrell, Mireia López-Corbeto et al. · Seminars in Arthritis and Rheumatism · 2020 · 151 citations · Full text

Medicine, Internal Medicine, Pharmacotherapy +10

Conventional Cancer Screening versus PET/CT in Dermatomyositis/Polymyositis

Albert Selva-O’Callaghan, Josep M. Grau, Cristina Gámez‐Cenzano et al. · The American Journal of Medicine · 2010 · 149 citations

Medicine, Oncology, Radiology +12